Sarepta jumps on JP Morgan update, gene therapy DMD deals – FierceBiotech
|
Sarepta jumps on JP Morgan update, gene therapy DMD deals
FierceBiotech The research deals are with Nationwide Children's Hospital and will see the pair work on their microdystrophin gene therapy program, as well as another form of gene therapy. An initial phase 1/2a trial for the microdystrophin gene therapy is slated to … |
